Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Beta-Glucans and Saccharomyces Boulardii are closely matched across evidence, studies, and safety.
Verdict
Likely helps
14 of 16 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
13 of 15 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Beta-Glucans and Saccharomyces Boulardii have evidence — compare verdict strength side-by-side.
250-500mg yeast beta-glucan OR 3g oat beta-glucan for cholesterol
Morning, With or without food
Yeast-derived 1,3/1,6 beta-glucan (Wellmune is most studied)
250-500mg (5-10 billion CFU) daily
With or without food, At least 2 hours away from antifungals
Capsules (lyophilized)
4-12 weeks
During illness
4-8 weeks
During use
1-3 days
1-2 weeks
Galactomannans are the most effective soluble dietary fibers in type 2 diabetes: a systematic review and network meta-analysis
The American journal of clinical nutrition (2023) · Meta analysis · n=2685
Galactomannans had the highest effect on reducing the levels of HbA1c (SUCRA: 92.33%) and fasting blood glucose (SUCRA: 85.92%).
Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Nutrients (2022) · Meta analysis · n=927
The results were presented with the weighted mean difference (WMD) with a 95% CI.
A systematic review and meta-analysis of beta-glucan consumption on glycemic control in hypercholesterolemic individuals
International journal of food sciences and nutrition (2015) · Meta analysis · n=603
Summary estimates of weighted mean differences (WMD) and 95% confidence interval was 0.05 mmol/L (-0.11, 0.02) for fasting glucose concentration and 0.75 pmol/L (-1.82, 3.32) for fasting insulin concentrations.
Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis
Frontiers in cellular and infection microbiology (2025) · Meta analysis · n=5036
S. boulardii supplementation in traditional eradication therapy significantly improves the H. pylori eradication rate and reduces the total adverse effects and incidence of diarrhea, bloating, constipation, and nausea.
Probiotics for treating acute infectious diarrhoea
The Cochrane database of systematic reviews (2020) · Meta analysis · n=12127
Effect size was similar in the sensitivity analysis and marked heterogeneity persisted.
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes
Gut microbes (2024) · Meta analysis · n=2871
This review aims to analyze available evidence from human-controlled trials to determine the effect size of probiotic interventions in decolonizing AMR pathogenic bacteria from the gut.
Based on multiple meta-analyses showing 0.24-0.32 mmol/L LDL reduction. Effect specific to oat beta-glucan, not yeast forms. FDA-approved health claim at 3g dose. GI side effects more common with oat forms.
Based on multiple meta-analyses showing 1.1-1.6 day reduction in diarrhea duration. Effect size appears to plateau at standard therapeutic doses. Limited data on doses above 20 billion CFU.
AI-estimated from published studies. Interpret as directional guidance.
Both Beta-Glucans and Saccharomyces Boulardii are closely matched — the best choice depends on your specific health goals.
For support immune system, Beta-Glucans has a higher relevance score (95 vs 60).
No known interactions between Beta-Glucans and Saccharomyces Boulardii have been documented in our database. However, always consult a healthcare provider before combining supplements.